Nabla Bio
AI-driven generative platform for de novo design of drug-like antibodies and medicines using integrated patient-relevant testing.
Información de la herramienta
¿Qué es Nabla Bio?
Nabla Bio is an AI-driven generative platform that makes drug development a true design discipline. It combines generative de novo drug design with large-scale human-relevant testing and integrated dry/wet-lab systems to produce safer, more precise medicines that reach patients faster.
Características principales
Generative de novo drug design
AI-powered generation of drug candidates, including drug-like antibodies, directly from computational methods.
Patient-relevant testing integration
Combines generative design with large-scale human-relevant testing to convert trial-and-error discovery into engineerable success.
Integrated dry/wet-lab engine
Owns and unifies data, AI models, and dry/wet-lab systems to design medicines targeting binding, developability, cellular function, and in-vivo performance.
JAM-2 antibody generation
Produces drug-like antibodies straight from the computer as part of the generative design pipeline.
Casos de uso
- #1
Pharmaceutical partnership drug design
Collaborative design of new medicines with leading pharmaceutical companies to bring safer and more precise drugs to patients.
- #2
Antibody and target expansion
Design of novel antibodies and medicines that unlock new targets and expand treatment frontiers.
Alternativas
Preguntas frecuentes
What is Nabla Bio?
What does Nabla Bio's JAM-2 technology do?
Who does Nabla Bio partner with?
Where is Nabla Bio based?
Is pricing information available for Nabla Bio?
Nabla Bio Contacto y redes sociales
- EmpresaNabla Bio, Inc
- DirecciónRiverside Technology Center 840 Memorial Dr Cambridge, MA 02139
- Correo electrónico de soporte
- Sitio web:
- Twitter
- LinkedIn
Reseñas
Comparte tu experiencia con esta herramienta...